Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The New England Journal of Medicine|April 1, 1993
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study WorkgroupS J Winawer, A G Zauber, M J O'Brien, et al.
The New England Journal of Medicine|January 11, 1996
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study WorkgroupS J Winawer, A G Zauber, H Gerdes, et al.
Cancer|September 1, 1992
The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study WorkgroupS J Winawer, A G Zauber, M J O'Brien, et al.
The New England Journal of Medicine|December 30, 1993
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study WorkgroupS J Winawer, A G Zauber, M N Ho, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Phase I study of docetaxel and topotecan in patients with solid tumorsK H Tkaczuk, W C Zamboni, N S Tait, et al.
The New England Journal of Medicine|June 15, 2000
A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work GroupS J Winawer, E T Stewart, A G Zauber, et al.
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerJ A Treat, R Gonin, M A Socinski, et al.
Clinical and Translational Science|January 22, 2016
Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics ModelingC H Li, R R Bies, Y Wang, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium TrialP N Lara, D R Gandara, J Longmate, et al.
Pageof 8